Plain-English translation of NCT06635213 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Carpal tunnel syndrome causes pain, numbness, and weakness in the hand and wrist. Some people with this condition have pain that persists because their nervous system has become overly sensitive — a condition called nocioplastic pain. This trial tests whether combining a desensitization technique (gradually retraining your hand to tolerate touch and sensation) with education about how pain works can reduce symptoms better than desensitization alone.
Standard treatments for carpal tunnel syndrome don't always work well for people whose pain is driven by nervous system sensitization rather than just nerve compression. Learning how pain actually works in the brain may help people manage their symptoms more effectively when combined with hands-on retraining.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. Both groups will receive desensitization therapy — hands-on retraining to help your hand tolerate sensation again. One group will also receive education sessions about how pain and your nervous system work together. You'll be assessed at the start, right after treatment ends, and again three months later using questionnaires and physical tests to measure your pain, symptoms, and hand function.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Kutahya Health Sciences University
Enrollment target
~40 participants
Started
October 2024
Primary completion
April 2027
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Emrah Afsar, Phd
Kutahya Health Sciences University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.